Press News

Press News

Press News | 17.11.2026

 

Read the related publicity here

 

Web Monitoring Report for the period 16/11 – 17/11

Title Media Publ. Date
Kos Biotechnology Partners: Establishes a biotech hub in Crete and plans four new deals by the end of 2026 capital.gr 17/11/2026
Enterprise Greece: Greek exports of chemicals and related products reached €6.3 billion in 2025 capital.gr 16/11/2026
High-cost medicines, IFET and capped budgets: Findings from four ISPOR 2026 studies dailypharmanews.gr 17/11/2026
Merck announces new highly skilled positions in Athens – Professionals sought healthpharma.gr 16/11/2026
EOPYY reviews past charges and overbilling practices – What investigators are examining healthreport.gr 17/11/2026
Pharmacists can administer vaccines in 19 European countries iatronet.gr 16/11/2026
Leadership change at Sobi: Elisavet Prodromou appointed Country Manager for Greece, Cyprus and Malta mononews.gr 16/11/2026
Before deciding on a medicine, we need to know what has changed naftemporiki.gr 17/11/2026
Mariangela Oikonomopoulou appointed Country Lead Greece at UCB naftemporiki.gr 16/11/2026
Two letters from the Panhellenic Federation of Kidney Patients calling for immediate solutions to critical issues affecting kidney patients news4health.gr 16/11/2026
Marios Themistocleous presents the “Prolamvano” prevention programme at a European ministerial panel in Ireland: “Helping people avoid becoming patients” parapolitika.gr 16/11/2026
WHO warns that rising antibiotic resistance could cause 39 million deaths over 25 years protothema.gr 16/11/2026
EMA recommends approval of seven new medicines in Europe ygeiamou.gr 17/11/2026
Free provision of obesity medicines delayed – First stage of the process begins today ygeiamou.gr 17/11/2026
Skip to content
SFEE

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.